Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
dabrafenib
.
Show all posts
Showing posts with label
dabrafenib
.
Show all posts
Monday, July 17, 2017
Researchers report high response rate with single drug in phase I/II trial of paediatric brain cancer
›
In continuation of my update on Dabrafenib A high response rate with a single drug in a phase I/II trial of paediatric brain tumo...
Monday, June 10, 2013
FDA Approves Tafinlar (dabrafenib) for Advanced Melanoma
›
In conyinaution of my update on Dabrafenib GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA...
Wednesday, August 8, 2012
Kinase Inhibitor Trials Show Melanoma Benefits | News | Drug Discovery and Development Magazine
›
Findings from GlaxoSmithKline (GSK) plc’s Phase 3 clinical study program evaluating single agent therapy with the targeted anti-cancer ag...
Tuesday, June 19, 2012
Phase I clinical trial shows drug shrinks melanoma brain metastases
›
The drug dabrafenib (see structure), which targets the Val600 BRAF mutation that is active in half of melanoma cases, also cut the size o...
›
Home
View web version
